sCD163 and sMR in Wilsons Disease – Associations With Disease Severity and Fibrosis

Brief Title

sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis

Official Title

Macrophages and the Macrophage Activation Markers sCD163 and Mannose Receptor (sMR) in Patients With Wilsons Disease - Associations With Liver Disease Severity and Fibrosis

Brief Summary

      The aim is to investigate macrophage activation markers and correlations to liver fibrosis in
      patients with Wilsons Disease. Researchers wish to investigate associations to neurologic and
      metabolic liver function. Researchers will assess this by comparing blood samples with
      fibrosis and liver function analyses. This study provides new insight into macrophages and
      their involvement in Wilsons Disease.
    

Study Type

Interventional

Primary Outcome

Measurement of the macrophage activation markers sCD163

Secondary Outcome

 Urinary copper excretion in 24 hour urine collection

Condition

Wilsons Disease

Intervention

Fibroscan

Study Arms / Comparison Groups

 Wilsons disease

Description:  All patients will receive all interventions (galactose elimination capacity test , ultrasound, fibroscan, continuous reaction time test and functional hepatic nitrogen clearance ), except liver biopsy.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Status

Procedure

Estimated Enrollment

33

Start Date

February 2016

Completion Date

February 2022

Primary Completion Date

February 2020

Eligibility Criteria

        Inclusion Criteria:

          -  diagnosed with Wilsons disease

        Exclusion Criteria:

        -
      

Gender

All

Ages

18 Years - 100 Years

Accepts Healthy Volunteers

No

Contacts

Henning Grønbæk, Professor, , 

Location Countries

Denmark

Location Countries

Denmark

NCT ID

NCT02702765

Organization ID

Wilson sCD163

Responsible Party

Sponsor

Study Sponsor

University of Aarhus

Collaborators

 Aarhus University Hospital

Study Sponsor

Henning Grønbæk, Professor, Principal Investigator, Aarhus University Hospital, Nørrebrogade 44, Aarhus C, Denmark, 8000

Verification Date

November 2022